Healthcare provider profile · identity verified

Mary V Corrigan, MD

Family Practice · CLEVELAND, OH · NPI 1669587572

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	775	223
Lisinopril	Lisinopril	448	136
Levothyroxine Sodium	Levothyroxine Sodium	366	104
Amlodipine Besylate	Amlodipine Besylate	351	119
Metoprolol Succinate	Metoprolol Succinate	270	82
Omeprazole	Omeprazole	265	93
Losartan Potassium	Losartan Potassium	264	80
Hydrochlorothiazide	Hydrochlorothiazide	252	78
Rosuvastatin Calcium	Rosuvastatin Calcium	179	53
Gabapentin	Gabapentin	171	44
Metformin Hcl	Metformin Hcl	163	55
Fluticasone Propionate	Fluticasone Propionate	126	41
Simvastatin	Simvastatin	119	34
Metoprolol Tartrate	Metoprolol Tartrate	117	33
Atenolol	Atenolol	110	33
Citalopram Hbr	Citalopram Hydrobromide	104	36
Albuterol Sulfate Hfa	Albuterol Sulfate	101	45
Metformin Hcl Er	Metformin Hcl	101	37
Allopurinol	Allopurinol	92	28
Eliquis	Apixaban	85	21
Pravastatin Sodium	Pravastatin Sodium	84	23
Glipizide	Glipizide	81	22
Pantoprazole Sodium	Pantoprazole Sodium	81	28
Alendronate Sodium	Alendronate Sodium	80	22
Furosemide	Furosemide	80	28
Sertraline Hcl	Sertraline Hcl	73	20
Synthroid	Levothyroxine Sodium	69	21
Carvedilol	Carvedilol	61	18
Montelukast Sodium	Montelukast Sodium	61	17
Duloxetine Hcl	Duloxetine Hcl	58	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	16
Hydralazine Hcl	Hydralazine Hcl	55	13
Trazodone Hcl	Trazodone Hcl	53	15
Bupropion Xl	Bupropion Hcl	51	13
Potassium Chloride	Potassium Chloride	48	19
Ibuprofen	Ibuprofen	47	11
Trulicity	Dulaglutide	46	12
Xarelto	Rivaroxaban	45	12
Escitalopram Oxalate	Escitalopram Oxalate	44	15
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Januvia	Sitagliptin Phosphate	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Jardiance	Empagliflozin	43	14
Tamsulosin Hcl	Tamsulosin Hcl	42	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	14
Lovastatin	Lovastatin	39	11
Clopidogrel	Clopidogrel Bisulfate	38	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Spironolactone	Spironolactone	35	13
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	34	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	11
Famotidine	Famotidine	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	12
Doxazosin Mesylate	Doxazosin Mesylate	30	11
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Dulera	Mometasone/Formoterol	29	suppressed
Ketoconazole	Ketoconazole	29	13
Azithromycin	Azithromycin	27	26
Meloxicam	Meloxicam	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Estradiol	Estradiol	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Naproxen	Naproxen	20	suppressed
Valsartan	Valsartan	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Ozempic	Semaglutide	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Acyclovir	Acyclovir	14	suppressed
Baclofen	Baclofen	14	suppressed
Colchicine	Colchicine	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Ibu	Ibuprofen	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Clonidine	Clonidine	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error